Biolinq
Latest round
- Series C
Last raised
- Mar 2025
Total raised
- $173M
Investors
- 20
About Biolinq
Based in California, US, Biolinq Inc. provides an electrochemical sensor for measuring metabolic health., Ltd., Ltd. As of 2024, the company is headed by its CEO Rich Yang. Biolinq's product is a biowearable platform that utilizes a multi-sensor array to detect and monitor various metabolic analytes, such as glucose, directly through the skin. This platform offers continuous, real-time feedback on metabolic health, using an array of ultra-small, electrochemical sensors.
Who invested in Biolinq
20 investors across 4 rounds
See all investors in Biolinq
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Biolinq
Who invested in Biolinq?
Biolinq has 20 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Biolinq raised?
Biolinq has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Biolinq last raise money?
Biolinq's most recent round on record is a Series C, in Mar 2025.
What does Biolinq do?
Based in California, US, Biolinq Inc.
Where is Biolinq headquartered?
Biolinq is headquartered in San Diego, US.
Which VCs invest in companies like Biolinq?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Biolinq's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series C
Raising like Biolinq? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.